Giovanni Benedetti

2.2k total citations · 1 hit paper
20 papers, 1.5k citations indexed

About

Giovanni Benedetti is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giovanni Benedetti has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giovanni Benedetti's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Risks and Factors (4 papers) and Cancer Treatment and Pharmacology (4 papers). Giovanni Benedetti is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Risks and Factors (4 papers) and Cancer Treatment and Pharmacology (4 papers). Giovanni Benedetti collaborates with scholars based in Italy, United States and United Kingdom. Giovanni Benedetti's co-authors include Alfredo Falcone, Gianluca Masi, S. Vitello, V. Picone, I. Brunetti, Cristina Granetto, E. Pfanner, M. Andreuccetti, C. Barbara and Lucio Crinò and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and CHEST Journal.

In The Last Decade

Giovanni Benedetti

20 papers receiving 1.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

2007 872 citations Alfredo Falcone, Sergio Ricci et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giovanni Benedetti Italy	15	1.1k	444	367	314	244	20	1.5k
Jeroen Hagendoorn Netherlands	23	1.1k 1.0×	325 0.7×	363 1.0×	413 1.3×	882 3.6×	95	1.9k
M Julien France	20	477 0.4×	575 1.3×	198 0.5×	142 0.5×	587 2.4×	42	1.3k
Zhen Huang China	18	480 0.4×	257 0.6×	267 0.7×	249 0.8×	321 1.3×	104	1.2k
Yin‐Hsun Feng Taiwan	20	475 0.4×	217 0.5×	195 0.5×	732 2.3×	198 0.8×	69	1.5k
Keaton Jones United Kingdom	17	691 0.6×	60 0.1×	263 0.7×	320 1.0×	387 1.6×	28	1.6k
Kate Cameron Netherlands	8	1.2k 1.1×	87 0.2×	197 0.5×	1.0k 3.3×	106 0.4×	14	2.0k
Irving Taylor United Kingdom	10	281 0.3×	190 0.4×	123 0.3×	100 0.3×	163 0.7×	30	657
Lister Hill United States	6	556 0.5×	158 0.4×	144 0.4×	152 0.5×	176 0.7×	6	824
Xinyuan Lu China	19	321 0.3×	291 0.7×	189 0.5×	659 2.1×	233 1.0×	47	1.3k
Takanori Ochiai Japan	20	469 0.4×	251 0.6×	215 0.6×	270 0.9×	329 1.3×	73	1.1k

Countries citing papers authored by Giovanni Benedetti

Since Specialization

Citations

This map shows the geographic impact of Giovanni Benedetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Benedetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Benedetti more than expected).

Fields of papers citing papers by Giovanni Benedetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Benedetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Benedetti. The network helps show where Giovanni Benedetti may publish in the future.

Co-authorship network of co-authors of Giovanni Benedetti

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Benedetti. A scholar is included among the top collaborators of Giovanni Benedetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Benedetti. Giovanni Benedetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ballatore, Z., Filippo Merloni, Luca Cantini, et al.. (2021). Cancer patient perspective in the arena of COVID‐19 pandemic. Psycho-Oncology. 31(1). 39–45. 12 indexed citations

Lambertini, Matteo, Niels Kroman, Lieveke Ameye, et al.. (2017). Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status. JNCI Journal of the National Cancer Institute. 110(4). 426–429. 119 indexed citations

Lambertini, Matteo, Niels Kroman, Lieveke Ameye, et al.. (2017). Safety of pregnancy in patients (pts) with history of estrogen receptor positive (ER+) breast cancer (BC): Long-term follow-up analysis from a multicenter study.. Journal of Clinical Oncology. 35(15_suppl). LBA10066–LBA10066. 2 indexed citations

Finicelli, Mauro, Giovanni Benedetti, Tiziana Squillaro, et al.. (2014). Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence. Oncotarget. 5(20). 9678–9688. 38 indexed citations

Pistilli, Barbara, Elisa Giovannetti, Giovanni Codacci-Pisanelli, et al.. (2012). Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding?. Cancer Treatment Reviews. 39(3). 207–211. 41 indexed citations

Ferruzzi, Pietro, Antonella Rosa, Cinzia Giordano, et al.. (2011). In vitro and in vivo characterization of a novel hedgehog signaling antagonist in human glioblastoma cell lines. International Journal of Cancer. 131(2). E33–44. 38 indexed citations

Pivot, Xavier, Andreas Schneeweiß, Shailendra Verma, et al.. (2011). Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO. European Journal of Cancer. 47(16). 2387–2395. 81 indexed citations

Cognetti, F., Stefania Gori, Vincenzo Adamo, et al.. (2010). NEMESI: A retrospective observational longitudinal study to investigate italian early breast cancer (EBC) patient characteristics and treatment.. Journal of Clinical Oncology. 28(15_suppl). e11046–e11046. 15 indexed citations

10.

Falcone, Alfredo, Sergio Ricci, I. Brunetti, et al.. (2007). Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest. Journal of Clinical Oncology. 25(13). 1670–1676. 872 indexed citations breakdown →

11.

Falcone, Alfredo, M. Andreuccetti, Cinzia Orlandini, et al.. (2007). Randomized phase III study of FOLFOXIRI (irinotecan, oxaliplatin and infusional 5FU/LV) vs FOLFIRI (irinotecan and 5FU/LV) as first-line treatment of metastatic colorectal cancer (MCRC): Subgroup and multivariate analysis. CINECA IRIS Institutial research information system (University of Pisa). 2 indexed citations

12.

Falcone, Alfredo, Gianluca Masi, I. Brunetti, et al.. (2006). The triplet combination of irinotecan, oxaliplatin and 5FU/LV (FOLFOXIRI) vs the doublet of irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal cancer (MCRC): Results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.). Journal of Clinical Oncology. 24(18_suppl). 3513–3513. 19 indexed citations

13.

Falcone, Alfredo, Gianluca Masi, Giovanni Benedetti, et al.. (2006). Biweekly irinotecan, oxaliplatin, and infusional 5-FU/LV (FOLFOXIRI) versus FOLFIRI as first-line treatment of metastatic colorectal cancer (MCRC): Results of a randomized, phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.). CINECA IRIS Institutial research information system (University of Pisa). 18 indexed citations

14.

Alifano, Marco, Giovanni Benedetti, & Rocco Trisolini. (2004). Can Low-Molecular-Weight Heparin Improve the Outcome of Patients With Operable Non-Small Cell Lung Cancer?. CHEST Journal. 126(2). 601–607. 14 indexed citations

15.

Craig, Peter J., Suchira Bose, Ruud Zwart, et al.. (2004). Stable expression and characterisation of a human α7 nicotinic subunit chimera: a tool for functional high-throughput screening. European Journal of Pharmacology. 502(1-2). 31–40. 24 indexed citations

16.

Sher, Emanuele, Yelin Chen, Giovanni Benedetti, et al.. (2004). Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity. Current Topics in Medicinal Chemistry. 4(3). 283–297. 75 indexed citations

17.

Chen, Ying, Keith G. Phillips, Giovanni Benedetti, et al.. (2003). The nicotinic α4β2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices. Neuropharmacology. 45(3). 334–344. 37 indexed citations

18.

Tommaso, Luca Di, Elisabetta Magrini, Alessandro Consales, et al.. (2002). Malignant granular cell tumor of the lateral femoral cutaneous nerve: Report of a case with cytogenetic analysis. Human Pathology. 33(12). 1237–1240. 21 indexed citations

19.

Tarella, Corrado, Giovanni Benedetti, Daniele Caracciolo, et al.. (1995). Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high‐dose chemotherapy + G‐CSF. British Journal of Haematology. 91(3). 535–543. 19 indexed citations

20.

Benedetti, Giovanni, P Bondesan, Daniele Caracciolo, et al.. (1994). Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.. PubMed. 22(2). 166–73. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact